New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Genetic vulnerability of leukemia cells uncovered

Genetic vulnerability of leukemia cells uncovered

Nov 22 2023Goethe-Universität Frankfurt am MainLeukemia is the most common type of cancer in children. Treatment involves intensive chemotherapy, which has severe side effects due to its non-specific
World medicine November 24,2023
Genetic vulnerability of leukemia cells uncovered

Genetic vulnerability of leukemia cells uncovered

Nov 22 2023Goethe-Universität Frankfurt am MainLeukemia is the most common type of cancer in children. Treatment involves intensive chemotherapy, which has severe side effects due to its non-specific
World medicine November 24,2023
PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction

PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction

Nov 21 2023European Society of Cardiology (ESC)The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its
World medicine November 24,2023
PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction

PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction

Nov 21 2023European Society of Cardiology (ESC)The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its
World medicine November 24,2023
BMF-219 Demonstrates Early Activity in Menin-Dependent AML

BMF-219 Demonstrates Early Activity in Menin-Dependent AML

July 25, 2023Caroline SeymourOral treatment with BMF-219 led to 2 complete responses of 5 patients with relapsed/refractory acute myeloid leukemia with menin-dependent mutations, both of which remain
World medicine November 24,2023
BMF-219 Demonstrates Early Activity in Menin-Dependent AML

BMF-219 Demonstrates Early Activity in Menin-Dependent AML

July 25, 2023Caroline SeymourOral treatment with BMF-219 led to 2 complete responses of 5 patients with relapsed/refractory acute myeloid leukemia with menin-dependent mutations, both of which remain
World medicine November 24,2023
Early Efficacy of BL-B01D1 in a Phase 1 Study Reflects Potential for ADCs in Lung Cancer and Beyond

Early Efficacy of BL-B01D1 in a Phase 1 Study Reflects Potential for ADCs in Lung Cancer and Beyond

August 11, 2023Courtney FlahertyHelena A. Yu, MD, discusses the investigation of BL-B01D1 in patients with advanced solid tumors, the potential significance of this research for those with EGFR-mutant
World medicine November 24,2023
Early Efficacy of BL-B01D1 in a Phase 1 Study Reflects Potential for ADCs in Lung Cancer and Beyond

Early Efficacy of BL-B01D1 in a Phase 1 Study Reflects Potential for ADCs in Lung Cancer and Beyond

August 11, 2023Courtney FlahertyHelena A. Yu, MD, discusses the investigation of BL-B01D1 in patients with advanced solid tumors, the potential significance of this research for those with EGFR-mutant
World medicine November 24,2023
Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

ByPooja Toshniwal PahariaOct 24 2023Reviewed byLily Ramsey, LLMIn a recent study published inCancer Cell, researchers combined deep microbial sequencing and targeted culturing of bac
World medicine November 24,2023
Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

ByPooja Toshniwal PahariaOct 24 2023Reviewed byLily Ramsey, LLMIn a recent study published inCancer Cell, researchers combined deep microbial sequencing and targeted culturing of bac
World medicine November 24,2023
ADCs and Radiotherapeutics Represent Novel Treatment Methods in RCC

ADCs and Radiotherapeutics Represent Novel Treatment Methods in RCC

July 15, 2023Chris RyanThe investigation of treatment regimens featuring antibody-drug conjugates or radiotherapeutics are part of the ongoing wave of research in renal cell carcinoma.Rana R. McKay, M
World medicine November 24,2023
ADCs and Radiotherapeutics Represent Novel Treatment Methods in RCC

ADCs and Radiotherapeutics Represent Novel Treatment Methods in RCC

July 15, 2023Chris RyanThe investigation of treatment regimens featuring antibody-drug conjugates or radiotherapeutics are part of the ongoing wave of research in renal cell carcinoma.Rana R. McKay, M
World medicine November 24,2023
Fluorescence lifetime imaging shows promise for improved tumor detection

Fluorescence lifetime imaging shows promise for improved tumor detection

Reviewed byLily Ramsey, LLMOct 16 2023Removing a patient's tumor while sparing healthy tissue requires exquisite precision, but often surgeons must rely on their eyes and hands to determine
World medicine November 24,2023
Fluorescence lifetime imaging shows promise for improved tumor detection

Fluorescence lifetime imaging shows promise for improved tumor detection

Reviewed byLily Ramsey, LLMOct 16 2023Removing a patient's tumor while sparing healthy tissue requires exquisite precision, but often surgeons must rely on their eyes and hands to determine
World medicine November 24,2023
Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

ByTarun Sai LomteSep 20 2023Reviewed byLily Ramsey, LLMIn a recent study published inNature Genetics, researchers evaluated sensitivity to immune checkpoint blockade (ICB) therapy in
World medicine November 24,2023
Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

ByTarun Sai LomteSep 20 2023Reviewed byLily Ramsey, LLMIn a recent study published inNature Genetics, researchers evaluated sensitivity to immune checkpoint blockade (ICB) therapy in
World medicine November 24,2023
Adoptive T Cell Therapy Applications

Adoptive T Cell Therapy Applications

ByShelley Farrar Stoakes, M.Sc., B.Sc.Reviewed bySophia CoveneyAdoptive T cell therapy is a promising type of immunological treatment that utilizes the immune system to fight diseases such
World medicine November 24,2023
Adoptive T Cell Therapy Applications

Adoptive T Cell Therapy Applications

ByShelley Farrar Stoakes, M.Sc., B.Sc.Reviewed bySophia CoveneyAdoptive T cell therapy is a promising type of immunological treatment that utilizes the immune system to fight diseases such
World medicine November 24,2023
Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

ByDr. Liji Thomas, MDJan 27 2021Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
World medicine November 24,2023
Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

ByDr. Liji Thomas, MDJan 27 2021Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
World medicine November 24,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com